B
BioLine RX Ltd
F:YP2A
BioLine RX Ltd
F:YP2A
Price:
2.98
EUR
Market Closed
Market Cap:
€238.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
BioLine RX Ltd
F:YP2A
|
IL |
|
Central Omega Resources Tbk PT
IDX:DKFT
|
ID |
|
M
|
Mizuho Leasing Co Ltd
TSE:8425
|
JP |
|
CPH Chemie und Papier Holding AG
SIX:CPHN
|
CH |
|
RWS Holdings PLC
OTC:RWSPF
|
UK |
|
Y
|
Yangarra Resources Ltd
OTC:YGRAF
|
CA |
|
L
|
Lonking Holdings Ltd
F:C9IB
|
CN |
|
R
|
Ryman Healthcare Ltd
XBER:RH7
|
NZ |
|
PPC Ltd
F:OZV2
|
ZA |
Multiples-Based Value
The Multiples-Based Value for BioLine RX Ltd (YP2A) under the Base Case is hidden EUR. Compared with the current market price of 2.98 EUR, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
YP2A Multiples-Based Value
LOCKED
